CN Patent

CN116675730A — 结合psma的双模式放射性示踪剂及治疗剂

Assigned to Technische Universitaet Muenchen · Expires 2023-09-01 · 3y expired

What this patent protects

本发明涉及根据式(V)的化合物或其药学上可接受的盐： 其任选地包含螯合的放射性阳离子并且其中F任选地为 18 F。

USPTO Abstract

本发明涉及根据式(V)的化合物或其药学上可接受的盐： 其任选地包含螯合的放射性阳离子并且其中F任选地为 18 F。

Drugs covered by this patent

Patent Metadata

Patent number
CN116675730A
Jurisdiction
CN
Classification
—
Expires
2023-09-01
Drug substance claim
No
Drug product claim
No
Assignee
Technische Universitaet Muenchen
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.